These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39138245)

  • 1. Identification of Chagas disease biomarkers using untargeted metabolomics.
    Herreros-Cabello A; Bosch-Nicolau P; Pérez-Molina JA; Salvador F; Monge-Maillo B; Rodriguez-Palomares JF; Ribeiro ALP; Sánchez-Montalvá A; Sabino EC; Norman FF; Fresno M; Gironès N; Molina I
    Sci Rep; 2024 Aug; 14(1):18768. PubMed ID: 39138245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet Alters Serum Metabolomic Profiling in the Mouse Model of Chronic Chagas Cardiomyopathy.
    Lizardo K; Ayyappan JP; Ganapathi U; Dutra WO; Qiu Y; Weiss LM; Nagajyothi JF
    Dis Markers; 2019; 2019():4956016. PubMed ID: 31949545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy.
    Díaz ML; Burgess K; Burchmore R; Gómez MA; Gómez-Ochoa SA; Echeverría LE; Morillo C; González CI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic insights in advanced cardiomyopathy of chronic chagasic and idiopathic patients that underwent heart transplant.
    de Oliveira RM; Paiva MUB; Picossi CRC; Paiva DVN; Ricart CAO; Ruperez FJ; Barbas C; Atik FA; Martins AMA
    Sci Rep; 2024 Apr; 14(1):9810. PubMed ID: 38684702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy.
    Nonaka CKV; Macêdo CT; Cavalcante BRR; Alcântara AC; Silva DN; Bezerra MDR; Caria ACI; Tavora FRF; Neto JDS; Noya-Rabelo MM; Rogatto SR; Ribeiro Dos Santos R; Souza BSF; Soares MBP
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations to the Cardiac Metabolome Induced by Chronic
    Hoffman K; Liu Z; Hossain E; Bottazzi ME; Hotez PJ; Jones KM; McCall LI
    ACS Infect Dis; 2021 Jun; 7(6):1638-1649. PubMed ID: 33843195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.
    Keating SM; Deng X; Fernandes F; Cunha-Neto E; Ribeiro AL; Adesina B; Beyer AI; Contestable P; Custer B; Busch MP; Sabino EC;
    Int J Cardiol; 2015 Nov; 199():451-9. PubMed ID: 26277551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy.
    Choudhuri S; Bhavnani SK; Zhang W; Botelli V; Barrientos N; Iñiguez F; Zago MP; Garg NJ
    Microbiol Spectr; 2021 Sep; 9(1):e0036421. PubMed ID: 34479416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.
    Wen JJ; Zago MP; Nuñez S; Gupta S; Burgos FN; Garg NJ
    Mol Cell Proteomics; 2012 Aug; 11(8):435-52. PubMed ID: 22543060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and mitochondria in the pathogenesis of chronic Chagas disease cardiomyopathy.
    Nunes JPS; Roda VMP; Andrieux P; Kalil J; Chevillard C; Cunha-Neto E
    Exp Biol Med (Maywood); 2023 Nov; 248(22):2062-2071. PubMed ID: 38235691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease.
    Cutrullis RA; Petray PB; Schapachnik E; Sánchez R; Postan M; González MN; Martín V; Corral RS
    PLoS One; 2013; 8(2):e57181. PubMed ID: 23451183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
    Laucella SA; de Titto EH; Segura EL
    Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: Correlation between antibody titers and development of cardiac disease severity.
    Georg I; Hasslocher-Moreno AM; Xavier SS; Holanda MT; Roma EH; Bonecini-Almeida MDG
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005796. PubMed ID: 28723905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signatures of CD4
    do Vale INPC; Almeida GG; Rimkute I; Liechti T; de Araújo FF; Dos Santos LI; Henriques PM; Rocha MODC; Elói-Santos SM; Martins Filho OA; Roederer M; Sher A; Jankovic D; Teixeira Carvalho A; Antonelli LRDV
    Front Immunol; 2024; 15():1385850. PubMed ID: 38726014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial metabolomics identifies localized chemical changes in heart tissue during chronic cardiac Chagas Disease.
    Dean DA; Gautham G; Siqueira-Neto JL; McKerrow JH; Dorrestein PC; McCall LI
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009819. PubMed ID: 34606502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic factor as marker of myocardial compromise in Chagas' disease.
    Puyó AM; Scaglione J; Auger S; Cavallero S; Donoso AS; Dupuy HA; Fernández BE
    Regul Pept; 2002 May; 105(2):139-43. PubMed ID: 11891014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Polymorphism at
    Batista AM; Alvarado-Arnez LE; Alves SM; Melo G; Pereira IR; Ruivo LAS; da Silva AA; Gibaldi D; da Silva TDESP; de Lorena VMB; de Melo AS; de Araújo Soares AK; Barros MDS; Costa VMA; Cardoso CC; Pacheco AG; Carrazzone C; Oliveira W; Moraes MO; Lannes-Vieira J
    Front Immunol; 2018; 9():615. PubMed ID: 29696014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi immunoproteome: Calpain-like CAP5.5 differentially detected throughout distinct stages of human Chagas disease cardiomyopathy.
    Caminha MA; de Lorena VMB; de Oliveira Júnior W; Perales J; Carvalho PC; Lima DB; Cavalcanti MDGAM; Martins SM; Valente RH; Menna-Barreto RFS
    J Proteomics; 2019 Mar; 194():179-190. PubMed ID: 30503829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic distribution of Trypanosoma cruzi genotypes detected in chronic infected people from Argentina. Association with climatic variables and clinical manifestations of Chagas disease.
    Bizai ML; Romina P; Antonela S; Olivera LV; Arias EE; Josefina DC; Silvia M; Walter S; Diana F; Cristina D
    Infect Genet Evol; 2020 Mar; 78():104128. PubMed ID: 31786340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.
    Thomas MC; Fernández-Villegas A; Carrilero B; Marañón C; Saura D; Noya O; Segovia M; Alarcón de Noya B; Alonso C; López MC
    Clin Vaccine Immunol; 2012 Feb; 19(2):167-73. PubMed ID: 22155766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.